BSP Push Spurs Wave of Lower Digital Transfer Fees Across Philippine Lenders
Digital money transfers in the Philippines are getting cheaper as banks and e-wallets cut or waive fees to comply with new pricing rules from the Bangko Sentral ng Pilipinas (BSP). The central...
Gokongwei to Take 15% Stake in PhilWeb With ₱2 Billion AI Push
PhilWeb Corp. secured a strategic equity investment of about ₱2.03 billion from businessman Lance Y. Gokongwei, giving the listed technology firm fresh capital to accelerate its expansion into...
Philippines Customs Chief Signals ‘All-Out War’ After ₱980 Million Cigarette Bust in Cebu
The Philippines’ Bureau of Customs is ramping up its campaign against illicit trade after intercepting an estimated ₱980 million worth of illicit cigarettes hidden in 25 container vans at a...
Philippines Defies Panel Market Slowdown With 145% Jump in Solar Imports
Filipino households are rushing to install rooftop solar systems in response to some of Southeast Asia’s highest electricity prices, propelling the Philippines to the top of global spending on...
UK Sees Supply-Chain Gains as Philippines Joins CPTPP Accession Pipeline
The Comprehensive and Progressive Agreement for Trans-Pacific Partnership is moving toward a new phase of expansion, with member economies agreeing to start preparatory discussions on potential...

Health Officials Hit With Misconduct Complaint on Alleged ‘Self-Policing’ Procurement

05.07.2026


Philippines Health Secretary Teodoro Herbosa and Undersecretary Randy Escolango are facing graft and administrative complaints before the Office of the Ombudsman, after a group of Department of Health (DOH) employees alleged the two officials engineered a centralized procurement setup that gave one official control over billions of pesos in public spending. The complainants, who identified themselves as “Concerned Department of Health Personnel,” accused the officials of creating a “closed-loop” or “closed procurement scheme” that allegedly bypassed statutory safeguards in the handling of medicines, vaccines and other medical supplies.

The case centers on two Department Personnel Orders (DPOs) issued in February 2026. According to the complaint, one order, DPO No. 2026-0700, granted Escolango oversight over both the Financial and Management Service and the Supply Chain Management Service. A second order, identified as DPO No. 2026-1080, reportedly designated him as chairperson of the Central Office Bids and Awards Committee-A (COBAC-A), the body with “exclusive jurisdiction” over high-value portfolios such as drugs and medicines, vaccines and other biological products, family planning pharmaceuticals and herbal medicines.

By combining these roles, the complainants argued, Escolango effectively presided over the entire lifecycle of DOH funds tied to major procurements — from budget programming and fund allocation to contract awards and the eventual distribution of supplies. The filing contends this “dual configuration” created what it described as an “absolute, self-policing conflict of interest,” neutralizing the independent financial and procurement checkpoints required under the country’s procurement laws. The complainants said the arrangement replaced transparent public bidding with an “unverified procurement framework” controlled by a single senior official.

Herbosa and Escolango were accused of violating Section 3(e) of Republic Act 3019, the Anti-Graft and Corrupt Practices Act, as well as provisions of Republic Act 12009, the New Government Procurement Act, which the complainants say mandate the segregation and independence of budget, procurement and logistics functions. They also face administrative allegations of grave misconduct and conduct prejudicial to the best interest of the service. The DOH employees urged the Ombudsman to place both officials under preventive suspension while the complaint is investigated, arguing that their continued presence could affect the integrity of any probe into the department’s multibillion-peso procurement operations.